C9orf78 | Chromosome 9 open reading frame 78 | | | | | | Expressed in all |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALU | Calumenin | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
CAPG | Capping protein (actin filament), gelsolin-like | Plasma proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CAPNS1 | Calpain, small subunit 1 | Plasma proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV2 | Caveolin 2 | Predicted membrane proteins
| | | | | Mixed |
CBFA2T2 | Core-binding factor, runt domain, alpha subunit 2; translocated to, 2 | | | | | | Expressed in all |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CBX1 | Chromobox homolog 1 | | | | | | Expressed in all |
CBX3 | Chromobox homolog 3 | Plasma proteins
| | | | | Expressed in all |
CCAR2 | Cell cycle and apoptosis regulator 2 | | | | | | Expressed in all |
CCBL2 | Cysteine conjugate-beta lyase 2 | Enzymes
| | | | | Expressed in all |
CCDC124 | Coiled-coil domain containing 124 | | | | | | Expressed in all |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
CCDC86 | Coiled-coil domain containing 86 | | | | | | Expressed in all |
CCNA2 | Cyclin A2 | Cancer-related genes
| | | | | Mixed |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNL2 | Cyclin L2 | Predicted secreted proteins
| | | | | Expressed in all |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCSAP | Centriole, cilia and spindle-associated protein | | | | | | Tissue enhanced |
CCT2 | Chaperonin containing TCP1, subunit 2 (beta) | Plasma proteins
| | | | | Expressed in all |
CCT5 | Chaperonin containing TCP1, subunit 5 (epsilon) | Disease related genes Plasma proteins
| | | | | Expressed in all |
CCT7 | Chaperonin containing TCP1, subunit 7 (eta) | Plasma proteins
| | | | | Expressed in all |
CCT8 | Chaperonin containing TCP1, subunit 8 (theta) | Plasma proteins
| | | | | Expressed in all |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD276 | CD276 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD2AP | CD2-associated protein | Disease related genes
| | | | | Expressed in all |
CD34 | CD34 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD37 | CD37 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes
| | | | | Mixed |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |